Taking Control of My Dry AMD
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The MacularDegeneration.net team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Khurana R. Lampalizumab shows preliminary benefits for slowing geographic atrophy. American Academy of Ophthalmology. https://www.aao.org/editors-choice/lampalizumab-shows-preliminary-benefits-slowing-ge. Published June 28, 2017.
- Holz FG, Sadda SR, Busbee B, et al. Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials. JAMA Ophthalmol. 2018;136(6):666–677. doi:10.1001/jamaophthalmol.2018.1544